Bayforest Capital’s Transmedics TMDX Stock Holding History

Bayforest Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-294	Closed	-$29.2K	–	1203
2026 Q1	$29.2K	Buy	+294	New	+$38.3K	0.03%	674

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Bayforest Capital's TMDX Position: Q2 2026 in Review

Bayforest Capital sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 294 shares — an estimated $29.2K sold.

Bayforest Capital first reported a position in TMDX in Q1 2026 and held it in 1 quarter. The position peaked at $29.2K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Bayforest Capital reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
Bayforest Capital sold 294 Transmedics shares in Q2 2026, an estimated $29.2K.
Bayforest Capital first reported a position in Transmedics in Q1 2026 and held it in 1 quarter.
Bayforest Capital's Transmedics position peaked at $29.2K in Q1 2026.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.